Identification of a pyroptosis-based model for predicting clinical outcomes from immunotherapy in patients with metastatic melanoma.

Wu, Guanghao; Chen, Biying; Jiang, Junjie; Chen, Yiran; Chen, Yanyan; Wang, Haiyong

Wu, Guanghao; Chen, Biying; Jiang, Junjie; Chen, Yiran; Chen, Yanyan; Wang, Haiyong.

Afiliação

Wu G; School of Clinical Medicine, Hangzhou Normal University Medical College, Hangzhou, China.
Chen B; Department of Surgical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jiang J; Department of Gastroenterology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Chen Y; Department of Surgical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Chen Y; Department of Surgical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wang H; Department of Surgical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Cancer Med ; 12(4): 4921-4937, 2023 02.

Article em En | MEDLINE | ID: mdl-36151761

Assuntos

Melanoma; Segunda Neoplasia Primária; Humanos; Piroptose; Melanoma/terapia; Imunoterapia; Imunização; Microambiente Tumoral; Prognóstico

Palavras-chave

durable clinical benefit; immunotherapy; melanoma; predictive model; pyroptosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Melanoma Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google